Narrow Results

PIXE technique was applied to the measurement of elements in the placenta, maternal blood and cord blood of human. The elements determined in these samples include Cl, K, Ca, Fe, Cu and Zn. The values obtained by PIXE were compared with those by ICP-AES to test the accuracy of the method. In placental samples, the mean values of K, Fe, Cu and Zn concentrations obtained by the two methods agree, while Ca concentration is lower in PIXE analysis. The values from PIXE, however, show larger variations resulting from inhomogeneity of the placental samples composed of various tissues different in histological functions. In the analysis of blood samples, the results of the two methods agree for Cl, K, Ca, Fe, Cu and Zn, although the standard deviations tend to be larger in PIXE. These results indicate that PIXE is a useful method for the determination of elements in placental and blood samples, although the preparation to homogenize sample is necessary to obtain accurate results.

Australia Finds New Hope in Treating Cystic Fibrosis.

Chinese Man with Transplanted Hands Cuts His Birthday Cake.

China Reveals Rice Genome Sequence.

Shanghai Cancer Survey Seeks Effective Treatments.

Tokyo Scientists Find Cloned Mice Have Shorter Lives.

Gene Study Sheds Light on Alzheimer's Disease.

Korean Researchers to Use DNA Chips for Cancer Study.

Pig Cell Procedure Pioneered by NZ Firm Spurs Diabetes Study.

Singapore World First to Use Cord Blood for Cancer Treatment.

Thai and US Medical Researchers Join Hands on Drug Project.

US Scientists Develops Device for Checking Blood Pressure in Heart.

Men Carrying Pollutant PCBs Have More Boys.

Keeping Up Intellectual Property Lifelines for Life Sciences Ventures.

Impact of the SARS Outbreak on the Australian Economy.

Body, Heal Thyself?

Interview with Beijing Tong Ren Tang/Science Arts.

Peptech and AVEO Pharmaceuticals Collaborate in Breakthrough Technology.

Progen Pharmaceuticals' Anti-Tumor Drug Candidate Receives FDA Fast Track Designation.

First TomoTherapy Patient Treatments Begin at Tata Memorial in India.

Panacea to Launch 15 New Vaccines in India in Two Years.

Japan's National Cancer Research Institute Improves on Lung Cancer Detection with Nonlinear's SameSpots Technology.

Alnylam Grants GeneDesign License to Provide RNA Interference Research Products.

Japan's Bioventures Today — Medical Collective Intelligence Co., Ltd.

CordLife Opens Cord Blood Facility in Jakarta.

GATC Biotech in Partnership to Develop DNA-Based Sepsis Diagnostic Test.

APEX Acquisition Strengthens PAREXEL's Leadership Position in the Asia Pacifc Region.

AUSTRALIA – First iPS Cell Line Puts Australia in the Lead of Stem Cell Research.

AUSTRALIA – New Treatment Hope for Prostate Cancer.

CHINA – AIDS Is China's Top Killer Among Infectious Diseases.

CHINA – Anti-bird Flu Drug for Human Clinical Trial Approved by China.

CHINA – China Plans 120 Billion Dollar Health Reform By 2011.

CHINA – 13 000 Fowl Culled in China After Bird flu.

CHINA – China-Russia Joint Research Center.

CHINA – Pig's Adult Stem Cells Produce Better Skins.

CHINA – More Health Scares Amid Slowdown, Warns China.

INDIA – Indian Experts Find Bacteria to Beat Global Heat.

INDIA – Two Indian Firms to set up Pre-clinical Trial Units in Malaysia.

JAPAN – Breakthrough in Universal Flu Vaccine Development.

SINGAPORE – Taiwan Pork Banned by AVA.

SINGAPORE – Stem-Cell Treatment For Joint Pain Gives New Hope.

SINGAPORE – Next Generation Healthcare Information System.

SINGAPORE – Top US University Sets up Research Centre in Singapore.

SINGAPORE – Increase in Life-saving Umbilical Cord Donations.

SINGAPORE – Singapore and China Scientists Report Breakthrough Research in Psoriasis.

SOUTH KOREA – Harmful Bacteria in French Baby Formula.

SOUTH KOREA – World's First Cloned Wolves to Test Reproductive Fitness.

TAIWAN – Genetic Testing on the Rise.

TAIWAN – Chinese Herbal Medicines Contain Western Drug Ingredients.

VIETNAM – Bird Flu Strikes in Five Provinces in Vietnam.

VIETNAM – Opening of Vietnam's First Stem Cell Bank, "MekoStem".

VIETNAM – Hanoi Suffers Worst Measles Outbreak in Decade.

OTHER REGIONS — EUROPE – Social Networking = Disease?

OTHER REGIONS — EUROPE – Cancer Morbidity 'to Double in 40 Years'.

OTHER REGIONS — NORTH AMERICA – Scientists Close in on 'Universal' Vaccine for Flu.

OTHER REGIONS — NORTH AMERICA – Hong Kong and US Scientists Develop New Bird Flu Vaccine.

AUSTRALIA – Tissue Engineering Hopes for Mastectomy Patients.

AUSTRALIA – Special Repair Enzyme in Kangaroos May Cure Skin Cancer.

AUSTRALIA – World's First Transgenic Sweet Sorghum.

AUSTRALIA – New Test Finds Chink in Cancer's Armor.

AUSTRALIA – Major Advance in Human Antibody Therapy against Deadly Nipah Virus.

AUSTRALIA – Centre of Kinomics to Open "Pandora's box" of Drug Development.

CHINA – H1N1 Influenza Death Toll Triples in China.

CHINA – China Okays GMO Rice Strain.

CHINA – Largest-Ever Liver Proteins Database – Roadmap to Treatments for Hepatitis.

CHINA – Two Longevity Genes Found.

CHINA – China and WHO Set Up Influenza Research Center in Beijing.

INDIA – Knowledge-Based Biotech Park in Himachal Pradesh.

INDIA – 25 Years On, Bhopal Water Still Toxic.

INDIA – Stem Cell Business Booms in India.

SINGAPORE – Genetic Mapping on World's Largest Ethnic Population Yields Invaluable Information.

SINGAPORE – Breakthrough Method to Study 3D Whole Genome Mapping.

SINGAPORE – Cord Blood Proves Positive for Cerebral Palsy Treatment.

SINGAPORE – Singapore the First in Asia to Launch New Biologic Treatment for Psoriasis.

SINGAPORE – Dealing with Climate Change at the 2010 World Cities Summit in Singapore.

SINGAPORE – Greater Cooperation on TCM Between Singapore and China.

TAIWAN – Patterns in Dengue Fever Outbreaks Identified.

TAIWAN – Taiwan and Canada Collaborate to Develop Asian Pneumonia Vaccine.

TAIWAN – New Nano-drug to Cure Cancer Patients.

TAIWAN – First Plant Medicine Center Operational in Taiwan.

OTHER REGIONS — EUROPE – Treat HIV Patients Sooner.

OTHER REGIONS — EUROPE – Studies Show Cancer Can be Passed on in the Womb.

OTHER REGIONS — NORTH AMERICA – Enzyme May Hold Key to Long Life.

OTHER REGIONS — NORTH AMERICA – United States Okays New Human Embryonic Stem Cell Lines for Research.

Mesoblast Limited Key Bone Repair Patent Granted In The United States.

Lilly to Acquire Global License to AXIRON Testosterone Solution from Acrux Tools.

China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank.

AutekBio to Build Largest Biologic CMO in Asia.

3SBio, Ascentage Pharma to Jointly Develop Cancer Therapeutics.

SIRO Clinpharm Forms Alliance with Korean CRO DreamCIS.

Ceragenix Enters into Agreement with Korea's BexPharm.

SRL Launches Sports Gene Test for the First Time in India.

Fortis Acquires Stake in Singapore's Parkway Holdings.

Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt.

AMPAC Fine Chemicals Partners With Inabata & Co., Ltd. of Japan.

Astellas Entered into Global Partnership with Basilea for an Azole Antifungal Agent Isavuconazole.

Medicago, NITT to Develop Vaccine in Japan.

Millipore Launches New Water Purification System for Ion Chromatography.

CSL to Set up Biotech Facility in Victoria.

Merck to Work with Sinopharm to Market HPV Shot and Other Vaccines in China.

China PharmaHub Corp. Signs Merger Agreement with World Wide Relics.

Lambda Therapeutic Research Acquires North American CRO.

Cochlear Commences Operations in India.

CordLife Introduces Quality Guarantee Program in India.

Opto Circuits Acquires US-based Unetixs Vascular.

Stem Cell-Based Treatment Collaboration for Corneal Vision Impairment, International Stem Cell Corporation.

Axiogenesis In-Licenses Yamanaka Patent Portfolio from iPS Academia Japan.

ArQule, Daiichi Sankyo to Conduct trials for NSCLC Drug.

Pfizer, Samsung Medical Center to Study Liver Cancer.

Agilent Technologies Signs Agreement with Government of Malaysia to Cooperate in Biotechnology.

Bayer Animal Health, Paraco Agree on Access to Lead Molecules.

A*STAR & Cytos Biotechnology Collaborate on Influenza Vaccine.

GE Healthcare Life Sciences take part in Life-Saving, Olivier Loeillot (GM of Bioprocess Asia).

Cennerv Pharma: A Company that Fights Along with Mental Illnesses.

How Can Cord Blood be Used to Save Lives? Life-Saving Mission of SCBB: An Interview with Dr. William Hwang.

An Interview with Mr. Stephen Ooi, Senior Executive Advisor Zimmer Biomet Asia Pacific.

APACMed – Serving Unmet Healthcare Needs in Asia Pacific, Fredrik Nyberg (CEO of APACMed).

Vaccination, One of the Solutions to Prevent Dengue Infection.

MonaLisa Touch^® Advanced Laser Treatment for Better Life Quality.

With approximately 130 million babies born worldwide every year umbilical cord blood represents perhaps the largest potential source of stem cells for regenerative medicine. Between 1972 and 2008, it is estimated that over 10,000 patients would have been treated by cord blood cells for over 80 different clinical conditions. Cord blood stem cells are used clinically mostly to support patients suffering from haematological and immunological diseases but they also provide emerging therapeutic solutions for limited cases of type 1 diabetes or infant cerebral injuries. Cord blood samples are collected after birth and bio-processed before cryopreservation in either public biobanks for unrelated allogenic use or private family biobanks for related allogenic and autologous uses. Regenerative medicine research demonstrated the existence of multipotent stem cells with embryonic characteristics in cord blood, which can produce over 20 tissue types including liver, neural or insulin-secreting cells. Cord blood stem cells not only offer therapeutic benefits at present but also show real potential for the advancement of regenerative medicine.

The observations that mice exposed to otherwise lethal irradiation could survive if their spleens or marrows were shielded, or if they received an infusion of bone marrow, led to the first attemps of bone marrow transplantation in humans in the mid-1950s by E. D. Thomas and J. Ferrebee. Thanks to Thomas' persistence despite criticism and initial clinical failures, and thanks to the development of a canine model of bone marrow transplantation by Thomas and Storb, the role of allogeneic hematopoietic cell transplantation (HCT) changed during the last 50 years from a desperate therapeutic maneouver plagued by apparently insurmountable complications to a curative treatment modality for thousands of patients with hematologic diseases. Further, it was recognized that allogeneic immunocompetent cells contained in the graft mediated therapeutic antitumor effects independent of the action of the high-dose therapy. These were termed graft-versus-tumor (GVT) effects. This prompted the recent development of non-myeloablative conditioning regimens for allogeneic HCT that have allowed offering this treatment modality in elderly patients and those with comorbid conditions. While hematopoietic stem cells were identified in the early 1960s, identification of other types of stem cells such as mesenchymal stem cells or embryonic stem cells might pave the way for stem cell therapy in regenerative medicine in the future.